Methylene Blue
Wellness
In plain English
Methylene blue is an old, FDA-approved medicine (a blue dye) used mainly to treat a specific blood problem called methemoglobinemia. At low doses it is also being explored for memory and brain-energy support. Dose matters a lot: low doses can be helpful/antioxidant, while high doses are harmful. It can interact dangerously with antidepressants (serotonin syndrome), turns urine blue-green, and must be used carefully.
The science
Methylene blue is a redox-active phenothiazine. Its FDA-approved use is treating acquired methemoglobinemia, where it acts through NADPH-methemoglobin reductase to reduce ferric (Fe3+) hemoglobin back to functional ferrous (Fe2+) hemoglobin. It shows a hormetic (dose-dependent, biphasic) profile: at low doses (~0.5-4 mg/kg) it acts as an alternative mitochondrial electron carrier that enhances cytochrome-c-oxidase activity, cerebral oxygen consumption, and memory in preclinical/small human studies (Rojas, Bruchey & Gonzalez-Lima, 2012), whereas high doses (>7 mg/kg) induce methemoglobinemia and oxidative stress. It is a monoamine-oxidase inhibitor and can precipitate serotonin syndrome with serotonergic drugs; contraindicated in G6PD deficiency. Cognitive/wellness uses are largely off-label.
References
- Rojas JC, Bruchey AK, Gonzalez-Lima F, Prog Neurobiol 2012 (review)
- Pushparajah Mak RS, Liebelt EL, Pediatr Emerg Care 2021 (methemoglobinemia)